Cargando…

Incorporation of biologic factors for the staging of de novo stage IV breast cancer

This study aimed to investigate the prognostic value of biological factors, including histological grade, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status in de novo stage IV breast cancer. Based on eligibility, patient data deposited bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Zhen-Yu, Lian, Chen-Lu, Wang, Jun, Lei, Jian, Hua, Li, Zhou, Juan, Wu, San-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477201/ https://www.ncbi.nlm.nih.gov/pubmed/32964117 http://dx.doi.org/10.1038/s41523-020-00186-5

Ejemplares similares

Additional radiotherapy to breast‐conserving surgery is an optional treatment for de novo stage IV breast cancer: A population‐based analysis
por: Wang, Jun, et al.
Publicado: (2021)

Staging for Breast Cancer With Internal Mammary Lymph Nodes Metastasis: Utility of Incorporating Biologic Factors
por: Lian, Chen-Lu, et al.
Publicado: (2021)

Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020)

Prognostic validation and treatment decision making of the 8(th) edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer
por: Wu, San-Gang, et al.
Publicado: (2020)

Prognostic validation and therapeutic decision‐making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy
por: Wu, San‐Gang, et al.
Publicado: (2020)

Impact of breast surgery in de novo stage IV breast cancer
por: Shien, Tadahiko
Publicado: (2019)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
por: Lee, Joanna S, et al.
Publicado: (2020)

Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020)

Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer
por: Shi, Jian, et al.
Publicado: (2020)

Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer
por: Huang, Zhen, et al.
Publicado: (2021)

Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma
por: Wu, San-Gang, et al.
Publicado: (2019)

Evaluation of the 8th edition of the American joint committee on cancer’s pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomy
por: Wu, San-Gang, et al.
Publicado: (2020)

Radiation therapy for primary tumor of de novo stage IV breast cancer
por: Yoshimura, Michio
Publicado: (2020)

Validation of the 8(th) edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients
por: Zhou, Juan, et al.
Publicado: (2020)

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis
por: Wu, San-Gang, et al.
Publicado: (2017)

A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer
por: Sun, Ming-Shuai, et al.
Publicado: (2021)

Could local surgery improve survival in de novo stage IV breast cancer?
por: Xiong, Zhenchong, et al.
Publicado: (2018)

Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023)

Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III–IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004–2014
por: Wu, San-Gang, et al.
Publicado: (2020)

Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making
por: Lian, Chen-Lu, et al.
Publicado: (2021)

Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
por: Heller, Danielle R., et al.
Publicado: (2019)

Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
por: Wang, Jun, et al.
Publicado: (2022)

Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With De Novo Stage IV Breast Cancer Based on SEER Database
por: Li, Kunlong, et al.
Publicado: (2021)

The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer
por: Yang, Shi-Ping, et al.
Publicado: (2022)

Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
por: Chen, Peng-Yu, et al.
Publicado: (2013)

Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer
por: Hassett, Michael J, et al.
Publicado: (2018)

Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)
por: Zheng, Ang, et al.
Publicado: (2021)

Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer
por: Zhou, Juan, et al.
Publicado: (2017)

The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study
por: Shao, Bin, et al.
Publicado: (2023)

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 as a Novel Biomarker for Breast Cancer
por: Zhou, Juan, et al.
Publicado: (2020)

The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV
por: Ge, Wei, et al.
Publicado: (2018)

Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis
por: Kim, Yi-Jun, et al.
Publicado: (2019)

Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020)

Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer
por: Kim, Byoung Hyuck, et al.
Publicado: (2020)

Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
por: Gera, Ritika, et al.
Publicado: (2020)

Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis
por: Wang, Xiaojuan, et al.
Publicado: (2022)

Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer
por: Li, Guan-Qiao, et al.
Publicado: (2022)

Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life
por: Si, Yiran, et al.
Publicado: (2020)

The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions
por: Miyashita, Minoru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_avidqo63s9e1nm64fm7s96eu6u